Liontrust Investment Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Sell |
131,756
-9,583
| -7% | -$264K | 0.05% | 135 |
|
|
2025
Q1 | $4.01M | Sell |
141,339
-8,907
| -6% | -$253K | 0.06% | 133 |
|
|
2024
Q4 | $6.25M | Buy |
150,246
+137,246
| +1,056% | +$5.71M | 0.09% | 116 |
|
|
2024
Q3 | $1.54M | Hold |
13,000
| – | – | 0.02% | 156 |
|
|
2024
Q2 | $1.54M | Sell |
13,000
-85,000
| -87% | -$10.1M | 0.02% | 156 |
|
|
2024
Q1 | $10.4M | Sell |
98,000
-18,000
| -16% | -$1.92M | 0.15% | 99 |
|
|
2023
Q4 | $11.5M | Buy |
116,000
+56,000
| +93% | +$5.57M | 0.17% | 94 |
|
|
2023
Q3 | $6.2M | Sell |
60,000
-14,000
| -19% | -$1.45M | 0.1% | 110 |
|
|
2023
Q2 | $8.99M | Buy |
74,000
+52,000
| +236% | +$6.32M | 0.13% | 99 |
|
|
2023
Q1 | $3.38M | Buy |
22,000
+4,000
| +22% | +$614K | 0.05% | 152 |
|
|
2022
Q4 | $3.23M | Sell |
18,000
-12,000
| -40% | -$2.16M | 0.06% | 117 |
|
|
2022
Q3 | $3.55M | Buy |
+30,000
| New | +$3.55M | 0.06% | 158 |
|
|
2021
Q4 | – | Sell |
-50,000
| Closed | -$19.2M | – | 225 |
|
|
2021
Q3 | $19.2M | Buy |
+50,000
| New | +$19.2M | 0.27% | 50 |
|